- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
May 29, 2001
Date of Report (date of earliest event reported)
SEQUENOM, INC.
- --------------------------------------------------------------------------------
(Exact name of Registrant as specified in charter)
Delaware 000-29101 77-0365889
- --------------------------------------------------------------------------------
(State or other (Commission File Number) (I.R.S. Employer
jurisdiction of Identification No.)
incorporation)
3595 John Hopkins Court
San Diego, California 92121
(Address of principal executive offices)
Registrant's telephone number, including area code: (858) 202-9000
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
- --------------------------------------------------------------------------------
Item 5. Other Events
------------
On May 29, 2001, Sequenom, Inc., a Delaware corporation ("Sequenom"), and
Gemini Genomics PLC, a company registered under the Companies Act of 1985 of
Great Britain, as amended ("Gemini"), entered into a Transaction Agreement dated
as of May 29, 2001, pursuant to which the parties agreed to merge their
businesses in a stock-for-stock exchange (the "Transaction").
Attached and incorporated herein by reference in its entirety as Exhibit
99.1 is a copy of the joint press release of Sequenom and Gemini announcing the
Transaction.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
------------------------------------------------------------------
(c) Exhibits
99.1 Joint Press Release dated May 29, 2001.
-2-
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: May 29, 2001 Sequenom, Inc.
/s/ Stephen L. Zaniboni
-------------------------------------------------
Stephen L. Zaniboni
Senior Vice President, Chief Financial Officer and
Secretary
(Principal Accounting Officer and Officer duly
authorized to sign this report on behalf of the
registrant.)
-3-
Exhibit Index
Exhibit Number Exhibit Title
- -------------- -------------
99.1 Joint Press Release dated May 29, 2001, announcing the
execution of the Transaction Agreement.